Inhibition of the HER2-YB1-AR axis with Lapatinib synergistically enhances Enzalutamide anti-tumor efficacy in castration resistant prostate cancer
about
Aloe-emodin inhibits HER-2 expression through the downregulation of Y-box binding protein-1 in HER-2-overexpressing human breast cancer cellsNovel agents for castration-resistant prostate cancer: Early experience and beyond.Investigational serine/threonine kinase inhibitors against prostate cancer metastases.ErbB2 Signaling Increases Androgen Receptor Expression in Abiraterone-Resistant Prostate Cancer.A Standardized Wedelia chinensis Extract Overcomes the Feedback Activation of HER2/3 Signaling upon Androgen-Ablation in Prostate CancerSynergy between Androgen Receptor Antagonism and Inhibition of mTOR and HER2 in Breast Cancer.Reactive oxygen species induction by cabazitaxel through inhibiting Sestrin-3 in castration resistant prostate cancer.Combination of Carmustine and Selenite Inhibits EGFR Mediated Growth Signaling in Androgen-Independent Prostate Cancer Cells.Integrative molecular network analysis identifies emergent enzalutamide resistance mechanisms in prostate cancer.Adaptive pathways and emerging strategies overcoming treatment resistance in castration resistant prostate cancer.miR372 Promotes Progression of Liver Cancer Cells by Upregulating erbB-2 through Enhancement of YB-1.Sprouty2 loss-induced IL6 drives castration-resistant prostate cancer through scavenger receptor B1.Enzalutamide-resistant castration-resistant prostate cancer: challenges and solutions
P2860
Q37644791-10FD3F25-A80D-4C0C-9D65-C3E994574A4FQ38574684-5374B962-0807-4453-B171-FD902016C937Q39021945-E2380120-6757-4866-BF32-63A5C5B8A540Q41768007-D52780CD-C3EF-451B-950C-FF5F28626E24Q42700424-4CDCDCD5-F80E-4049-82B1-CD35114602DEQ45058304-2759F50C-9F0E-4004-B878-1E6A323527E1Q46258836-7F92A572-F6E3-48C1-A131-514C838FBDD8Q48248291-9263D015-CD7F-4684-9CCB-C24C28018850Q49242804-62953278-2089-46C3-9B87-1F114B4F939EQ53735518-C31F14E3-F82C-405C-92D1-B6A11F5A295DQ54977356-B2DDF614-5AB1-42B5-B624-B16D6C340C8EQ54982147-2102B396-4613-432B-A8A6-9CF1BD55CBBDQ58698705-D07EE646-63CE-4E56-9ABB-34556A00CD44
P2860
Inhibition of the HER2-YB1-AR axis with Lapatinib synergistically enhances Enzalutamide anti-tumor efficacy in castration resistant prostate cancer
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Inhibition of the HER2-YB1-AR ...... tion resistant prostate cancer
@en
type
label
Inhibition of the HER2-YB1-AR ...... tion resistant prostate cancer
@en
prefLabel
Inhibition of the HER2-YB1-AR ...... tion resistant prostate cancer
@en
P2093
P2860
P356
P1433
P1476
Inhibition of the HER2-YB1-AR ...... tion resistant prostate cancer
@en
P2093
Amina Zoubeidi
Ario Takeuchi
Eliana Beraldi
Hidetoshi Kuruma
Jennifer L Bishop
Ka Mun Nip
Martin E Gleave
P2860
P304
P356
10.18632/ONCOTARGET.3602
P407
P577
2015-04-01T00:00:00Z